By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Karyopharm Therapeutics 

Newton  Massachusetts    U.S.A.
Phone: n/a Fax: n/a



Company News
Karyopharm Therapeutics (KPTI) Appoints Justin Renz Executive Vice President And Chief Financial Officer 8/8/2014 8:07:42 AM
Karyopharm Therapeutics (KPTI) To Present At The Wedbush 2014 Life Sciences Management Access Conference 8/8/2014 8:06:26 AM
Karyopharm Therapeutics (KPTI) Reports Second Quarter Financial Results For 2014 8/7/2014 8:15:11 AM
Karyopharm Therapeutics (KPTI) To Host Second Quarter 2014 Earnings Call On August 7, 2014 8/4/2014 7:48:49 AM
Karyopharm Therapeutics (KPTI) Announces Full Exercise Of Underwriters Option To Purchase Additional Shares In Public Offering Of Common Stock 6/30/2014 7:44:47 AM
Karyopharm Therapeutics (KPTI) Announces Pricing Of Public Offering of Common Stock 6/27/2014 7:24:26 AM
Karyopharm Therapeutics (KPTI) Announces Proposed Public Offering Of Common Stock 6/26/2014 7:40:39 AM
Karyopharm Therapeutics (KPTI) Initiates Registration-Directed, Randomized Study Of Selinexor (KPT-330) In Older Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) 6/24/2014 9:00:59 AM
Veristat, Inc. And Karyopharm Therapeutics (KPTI) Enter Into Preferred Provider Agreement For Oncology And Novel Therapeutic Advancement 6/16/2014 10:27:53 AM
Karyopharm Therapeutics (KPTI) Announces: FDA Considers The Effectiveness And Safety Technical Sections Complete To Support Conditional Approval For The New Animal Drug Application For Verdinexor (KPT-335) To Treat Lymphoma In Client Owned Dogs 6/16/2014 7:35:25 AM